Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021)

Sera Prognostics (SERA) reported Long-Term Debt Repayments of $1.4 million for Q4 2021, up 2150.0% on a YoY basis from $61955.6 in Q4 2020, and up 200.0% quarter-over-quarter from -$1.4 million in Q2 2021.

Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021) Analysis & Trends

Sera Prognostics has reported Long-Term Debt Repayments for 2 years, with the latest figure at $1.4 million in Q4 2021.

  • For the quarter ending Q4 2021, Long-Term Debt Repayments rose 2150.0% year-over-year to $1.4 million; the trailing twelve-month figure through Sep 2022 stood at $1.4 million (up 159.11% YoY), and the FY2021 full-year result was $4.5 million, changed N/A from the prior year.
  • Long-Term Debt Repayments for Q4 2021 stood at $1.4 million, up from -$1.4 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $2.0 million in Q1 2021, with the low at -$1.4 million in Q2 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.42 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.00 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Sera Prognostics 93.48 Mn 93.48 Mn -28,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 1.39 Mn
Dec 31, 2021 1.39 Mn
Jun 30, 2021 -1.39 Mn
Jun 30, 2021 -1.39 Mn
Mar 31, 2021 2.00 Mn
Mar 31, 2021 2.00 Mn
Dec 31, 2020 -68,000.00
Dec 31, 2020 -68,000.00
Sep 30, 2020 68,000.00
Sep 30, 2020 68,000.00